Pure Health Holding PJSC

**Summary:** PureHealth, the largest healthcare platform in the Middle East, has contributed AED 1 billion to local procurement since Q1 2023 to support the UAE's National In-Country Value (ICV) Programme. This initiative is part of the UAE's industrial strategy, aiming to boost the industrial sector's GDP contribution to AED 300 billion by 2031. During the Make it in the Emirates Forum, PureHealth confirmed its progress towards a target of AED 13 billion in local procurement by 2032. The company has also implemented ICV strategies across its operations, including subsidiaries like SEHA and Daman, achieving high ICV scores. These efforts underscore PureHealth's role in driving economic diversity, creating local jobs, and enhancing healthcare services in the UAE.

In Q1 2024, PureHealth reported a net profit of AED 491 million, a 124% increase from Q1 2023. The company's EBITDA also rose to AED 1.1 billion, a 2.3x increase from the previous year. This reflects improved operational efficiencies across all key segments. PureHealth's consolidated revenue increased by 52% to AED 6.1 billion, led by the Hospital and Other Related Services segment. The company completed the acquisition of Circle Health Group and Sheikh Shakhbout Medical City, significantly expanding its global presence. The firm's total assets increased to AED 47.3 billion, with a total cash balance of AED 8.0 billion. PureHealth's balance sheet reported a net cash balance of AED 4.4 billion as of 31 March 2024.

The text refers to the interim condensed consolidated financial statements of Pure Health Holding PJSC for the period ending on 31 March 2024. It is likely to contain financial information and performance indicators relevant to investors and those interested in the company's financial health.